Atlas Trials

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

Clinical trial NCT00294541 · TERMINATED

Trial details

NCT number
NCT00294541
Sponsor
Icagen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Sickle Cell DiseaseSickle Cell Anemia
Start date
2006-02-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.